Medical Doctor Program year 2024 Reported 2021–2024 Source: CMS Open Payments, 2026 publication

Anoop Koshy

Interventional Cardiology New York, NY Medical Doctor

NPI 1780350173 CMS profile 10407764

1468 Madison Avenue, Mount Sinai Heart, New York, NY 10029

Open in the dashboard

General payments

$21,828

324 records reported · program years 2021–2024

Research payments

$0

Paid to them · None reported · program years 2021–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Anoop Koshy of New York, NY is reported in the CMS Open Payments database as having received $21,828 across 324 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 76th percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $49 2
2023 General $5,018 88
2022 General $14,582 161
2021 General $2,179 73

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Anoop Koshy
  • Interventional Cardiology median
  • Middle half of Interventional Cardiology
  • National median

In program year 2025, general payments to Anoop Koshy were reported at $0. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.

Show as a table
Year Anoop Koshy Interventional Cardiology median Middle half National median
2019 $0 $1,097 $329–$3,048 $163
2020 $0 $473 $161–$1,480 $114
2021 $2,179 $677 $233–$1,827 $132
2022 $14,582 $978 $333–$2,724 $149
2023 $5,018 $1,136 $382–$2,986 $160
2024 $49 $1,181 $395–$3,326 $164
2025 $0 $1,092 $366–$3,019 $169

Breakdown

Who paid General payments · program years 2021–2024
  1. Medtronic, Inc. $10,285 30 payments
  2. Shockwave Medical, Inc $1,677 38 payments
  3. Osprey Medical Inc $1,250 1 payment
  4. Edwards Lifesciences Corporation $1,103 11 payments
  5. Terumo Medical Corporation $1,029 33 payments
  6. Cordis US Corp. $828 21 payments
  7. Boston Scientific Corporation $795 23 payments
  8. Abbott Laboratories $708 11 payments
  9. Bard Peripheral Vascular, Inc. $675 21 payments
  10. Chiesi USA, Inc. $605 28 payments
  11. Other $2,873 107 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2024
  1. Food and Beverage $10,459 296 payments
  2. Grant $7,334 1 payment
  3. Travel and Lodging $2,611 15 payments
  4. Consulting Fee $1,250 1 payment
  5. Education $174 11 payments
Products named General payments · program years 2021–2024
  1. COREVALVE EVOLUT R $2,877 27 payments
  2. DyeVert $1,250 1 payment
  3. Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter $1,150 24 payments
  4. KENGREAL $605 28 payments
  5. EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) $589 8 payments
  6. Vascular Lithotripsy $527 14 payments
  7. LifeVest $490 21 payments
  8. MYNX CONTROL $461 14 payments
  9. PK Papyrus $428 20 payments
  10. MITRACLIP $384 2 payments
  11. Other $6,217 219 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

324 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Cardiology in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record